secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0001493152-25-011706
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions preliminary Q4 revenue up ~16% sequentially and YoY, driven by cartridge sales
--------------------------------------------------------------------------------

- Preliminary Q4 FY2025 revenue growth of ~16% sequentially and year-over-year, driven by higher-margin cartridge sales and account growth.
- Submitted FDA 510(k) application for opiate test system (codeine) to support planned U.S. market entry.
- Completed multilingual system upgrades and launched localized websites to strengthen global adoption across Europe, Middle East, and Latin America.
- Full-year FY2025 results and Form 10-K expected to be filed during the week of August 11, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225011706/0001493152-25-011706-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225011706/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-011706

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer